Selective effects of DNA damaging agents on HIV long terminal repeat activation and virus replication in vitro

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 11, Issue 2, 1996, Pages 109-116

  Manome, Yoshinobu ^a   Yao, Xiao Jian ^b   Kufe, Donald W ^a   Cohen, Eric A ^b   Fine, Howard A ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Chemotherapy; DNA damage; Human immunodeficiency virus (HIV); Long terminal repeat (LTR); Radiation; Ultraviolet light

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; ANTINEOPLASTIC ALKALOID; ANTINEOPLASTIC ANTIBIOTIC; ANTINEOPLASTIC ANTIMETABOLITE; CAMPTOTHECIN; CARMUSTINE; CD4 ANTIGEN; CISPLATIN; CYTARABINE; DAUNORUBICIN; DNA; DOXORUBICIN; ETOPOSIDE; GYRASE INHIBITOR; HYDROGEN PEROXIDE; METHOTREXATE; MITOMYCIN C; TRANSCRIPTION FACTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; DNA DAMAGE; DRUG DNA INTERACTION; GENOTOXICITY; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IONIZING RADIATION; KAPOSI SARCOMA; LEUKEMIA CELL LINE; LONG TERMINAL REPEAT; LYMPHOCYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL; ULTRAVIOLET RADIATION; VIRUS ACTIVATION; VIRUS REPLICATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 1842510546     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199602010-00001     Document Type: Article

References (47)

1. Peterlin BM, Luciw PA. Molecular biology of HIV. AIDS 1988;2:29-40.
2. Rosenberg ZF, Fauci AS. Minireview: induction of expression of HIV in latently or chronically infected cells. AIDS Res Human Retroviruses 1989;5:1-4.
3. Ensoli B, Lusso P, Schacter F, et al. Human herpes virus-6 increase HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancer. EMBO J 1989;8:3019-27.
4. Fauci AS. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 1988;239:617-22.
5. Siekevitz M, Josephs SF, Dukovich M, et al. Activation of HIV-1 LTR by T cell mitogens and the trans-activator protein of the HTLV-1. Science 1987;238:1575-8.
6. Harada S, Kayanagi Y, Yamamoto N. Infection of HTLV-III/LAV in HTLV-1-carrying cells in MT-2 and MT-4 and application in a plaque assay. Science 1985;229:563-6.
7. Zimmerman K, Debrovnik M, Bllaun C, Beyec D, Hauber J, Bahnlein E. Transactivation of the HIV-1 LTR by the HIV-1 Tat and HTLV-1 Tat protein is mediated by different cisacting sequences. Virology 1991;182:874-8.
8. Scala G, Quinto I, Ruocco MR, et al. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repent of human immunodeficiency virus type 1. J Virol 1993;67:2853-61.
9. Swingler S, Easton A, Morris A. Cytokine augmentation of HIV-1 LTR driven gene expression in neural cells. AIDS Res Hum Retrovirus 1992;8:487-493.
10. Turpin JA, Vargo M, Meltzer MS. Enhanced HIV replication in retinoid-treated monocytes. Retinoid effects mediated through mechanisms related to cell differentiation and to a direct transcriptional action on viral gene expression. J Immunol 1992;148:2539-46.
11. Osborn L, Kunkel S, Nabel GJ. Tumor necrosis factor a and interleukin-1 stimulates the human immunodeficiency virus enhancer by activation of the nuclear factor aB. Proc Natl Acad Sci USA 1989;86:2336-40.
12. Stein B, Rahmsdorf HJ, Steffen A, Litfin M, Herrlich P. UV-induced DNA damage is an intermediate step in UV-induced expression of human immunodeficiency virus type 1, collagenase, c-fos, and metallothionein. Mol Cell Biol 1989;9:5169-81.
13. Valerie K, Delers A, Bruck C, et al. Activation of human immunodeficiency virus type 1 by DNA damage in human cells. Nature 1988;333:78-81.
14. Morrey JD, Bourn SM, Bunch TD, et al. In vivo activation of human immunodeficiency virus type 1 long terminal repeat by UV type A (UV-A) light plus psoralen and UV-B light in the skin of transgenic mice. J Virol 1991;65:
15. Valerie K, Rosenberg M. Chromatin structure implicated in activation of HIV-1 gene expression by ultraviolet light. New Biol 1990;2:712-8.
16. Lu Y, Stenzel M, Sodroski JG, Haseltine WA. Effects of long terminal repeat mutations on Human Immunodeficiency virus type I replication. J Virol 1989;63:4115-9.
17. Chan GL, Little JB. Induction of oncogene transformation induced by ultraviolet irradiation. Nature 1974;249:552-3.
18. Gilman ME, Wilson RN, Weinberg RA. Multiple protein binding sites in the 5′-flanking region regulates c-fos expression. Mol Cell Biol 1986;4305-16.
19. Yao XJ, Garzan S, Boisvert F, Haseltine WA, Cohen EA. The effect of vpu on HIV-1-induced syncytium formation. J Acquir Immune Defic Syndr 1993;6:135-41.
20. Lee MH, Morales FE, Imagma DT. Sensitive reverse transcriptase assay to detect and quantitate human immunodeficiency virus. J Clin Microbiol 1987;25:1717-21.
21. Boulerice F, Bour S, Geleziunas R, Lvovick A, Waiberg MA. High frequency of isolation of defective human immunodeficiency virus type 1 and heterogeneity of viral gene expression in clones of infected U-937 cells. J Virol 1990;64:1745-55.
22. Moscow JA, Cowan KH. Multidrug resistance. J Natl Cancer Inst 1988;88:14-20.
23. Sodroski J, Goh WC, Rosen C, et al. Replication and cytopathic potential of HTLV-III-LAV with scr gene deletions. Science 1986;231:1549-53.
24. Stanley SK, Folks TM, Fauci AS. Induction of expression of human immunodeficiency virus in a chronically infected promonocytic cell line by ultraviolet irradiation. AIDS Res Hum Retroviruses 1989;5:375-84.
25. Snyder RD, Houten Bv, Regan JD. Studies on the repair of ultraviolet- and methyl-methanesulfonate-induced damage in the DNA of human fibroblasts by novobiocin. Nucleic Acids Res 1982;10:6207-19.
26. Brooks P, Lawley PD. The actin of alkylating agents on deoxyribonucleic acid in relation to biological effects of the alkylating agents. Exp Cell Res 1963;9:512.
27. Brooks P, Lawley PD. The reaction of mono- and difunctional alkylating agents with nucleic acids. Biochem J 1961;80:486.
28. Major P, Egan EM, Beardsley G, Minden M, Kufe DW. Lethality of human myeloblasts correlates with the incorporation of ara-C into DNA. Proc Natl Acad Sci USA 1981;78:3235-9.
29. Friedberg EC. DNA repair. San Francisco: WH Freeman, 1984:23-59.
30. Jenh C-H, Geyer PK, Baskin F, et al. Thymidylate synthase gene amplification in fluoredeoxyuridase resistant neuro mouse cell lines. Mol Pharmacol 1985;28:80-5.
31. Belt JA, Neel DL. Isolation and characterization of a mutant of L1210 murine leukemia deficient in nitrobenzyl-thiosine-vincristine nucleoside transport. J Biol Chem 1988;263:13819-22.
32. Erickson LC, Laurent G, Sharkey MA, Kohn KW. DNA cross-linking and monoadduct repair in nitrosourea-treated human tumor cells. Nature 1980;288:727.
33. Walker GC. Mutagenesis and inducible responses to deoxyribonucleic acid damage in Escherichia coli. Microbiol Rev 1984;48:60.
34. Cohn SM, Lieberman MW. The distribution of DNA excision-repair sites in human diploid fibroblasts following ultraviolet irradiation. J Biol Chem 1984;259:12463-9.
35. Hanawalt PC, Cooper PK, Ganesan AK, Smith CA. DNA repair in bacteria and mammalian cells. Annu Rev Biochem 1979;48:783-835.
36. Francis AA, Snyder RD, Dunn WC, Regan JD. Classification of chemical agents as to their ability to induce long- or short-patch DNA repair in human cells. Mutat Res 1981;83:159-69.
37. Walker IG, Th'ng JPH. Excision-repair patch size in DNA from human KB cells treated with UV-light, or methly methanesulfonate. Mutat Res 1982;105:277-85.
38. Regan JD, Setlow RB. Two forms of repair in the DNA of human cells damaged by chemical carcinogens and mutations. Cancer Res 1974;34:3318-25.
39. Knox RJ, Friedles F, Lydall DA, Roberts JJ. Mechanisms of cytotoxicity of anticancer platinum drugs: Evidence that cisdiammine dichloroplacinum (11) and cis-diamine-(1,1-cyclobutane d-carboxylate) platinum (11) differ only in the kinetics of their interaction with DNA. Cancer Res 1986;46:1972.
40. Zwelling LA, Anderson T, Kolin KW. DNA-protein and DNA interstrand cross-linking by cis- and trans-platinum (11) diammine dichloride in L1210 mouse leukemia cells and relation to cytotoxicity. Cancer Res 1979;39:365.
41. Denny WA. DNA-intercalating ligands as anti-cancer drugs: prospects for future design. Anti cancer Drug Des 1989;4:241.
42. Baguley BC. DNA intercalating anti-tumor agents. Anti cancer Drug Des 1991;6:1.
43. Rice JA, Crothers DM, Pinto AI, Lippard SI. The major adduct of the antitumor drugs cis-diammine dichloro platinum (11) with DNA bends the duplex by 40 toward the major groove. Proc Natl Acad Sci USA 1988;85:4158-61.
44. Kharbanda SM, Sherman ML, Kufe DW. Transcriptional regulation of c-jun gene expression by arabinofuransylcytosine in human myeloid leukemia cells. J Clin Invest 1990;86:1517-23.
45. Sherman ML, Datta R, Hallahan DE, Weichselbaum RR, Kufe DW. Ionizing radiation regulates expression of the c-jun protooncogene. Proc Natl Acad Sci USA 1990;87:5663-6.
46. Manome Y, Datta R, Fine HA. Early response gene induction following DNA damage in astrocytoma cell lines. Biochem Pharmacol 1993;45:1677-84.
47. Yalkinoglu AO, Schlehofer JR, Hausen HZ. Inhibition of N-methyl-N'-nitro-N-nitrosoguanidine-induced methotrextate and adriamycin resistance in CHO cells by adenoassociated virus type 2. Int J Cancer 1990;45:1195-203.